Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
PAVmed Inc. - Series Z Warrant
(NQ:
PAVMZ
)
0.0009
UNCHANGED
Last Price
Updated: 1:52 PM EDT, Apr 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about PAVmed Inc. - Series Z Warrant
< Previous
1
2
Next >
PAVmed and Lucid Diagnostics Provide Strategic Business Update
January 17, 2023
From
PAVmed Inc.
Via
Business Wire
PAVmed and Lucid Diagnostics to Provide Strategic Business Update
January 11, 2023
From
PAVmed Inc.
Via
Business Wire
PAVmed Partners with Novosound on Ultrasound Imaging Technology
December 22, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry
December 08, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform
December 15, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research
December 01, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results
November 14, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed to Participate in BTIG Digital Health Forum
November 11, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
November 10, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer
November 09, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2022
November 03, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022
November 02, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech Conference
August 30, 2022
From
PAVmed Inc.
Via
Business Wire
PAVmed Provides Business Update and Preliminary Second Quarter 2022 Financial Results
August 16, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio
August 11, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® Technologies
August 04, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Chairman & CEO Lishan Aklog, M.D. Named to Savoy’s 2022 Most Influential Black Executives in Corporate America
July 19, 2022
From
PAVmed Inc.
Via
Business Wire
PAVmed to Hold a Business Update Conference Call on May 12, 2022
April 26, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 Conference
July 18, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
March 29, 2022
From
PAVmed Inc.
Via
Business Wire
PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO
May 13, 2022
From
PAVmed Inc.
Via
Business Wire
PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
March 23, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
March 17, 2022
From
PAVmed Inc.
Via
Business Wire
PAVmed Appoints Shaun O’Neil as Chief Operating Officer
February 24, 2022
From
PAVmed Inc.
Via
Business Wire
Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors
February 15, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference
February 10, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team
January 12, 2022
From
PAVmed Inc. and Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference
January 06, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth
December 01, 2021
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
November 17, 2021
From
Lucid Diagnostics Inc. PAVmed Inc.
Via
Business Wire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
